Pfizer: Omicron-specific COVID-19 Vaccine Human Trials To Begin Late January
(FOX 9) – Pfizer will begin human trials of an omicron-specific COVID-19 vaccine beginning in late January, a company spokesperson confirmed Monday to FOX TV Stations. “We already have begun work on a DNA template tailored to the sequence of Omicron, a critical step in the process of advancing a variant version of our vaccine if in fact, we find…